Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPGB vs Nasal Packing with Bupivacaine and Dexmedetomidine for Postoperative Analgesia
NCT07555821Phase 3Not yet recruiting
- Sponsor
- South Egypt Cancer Institute
- Start
- Apr 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine, dexmedetomidine in postoperative pain, sponsored by South Egypt Cancer Institute. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
bupivacainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07555821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07555821.